The PM Society Digital Awards have cemented their place as an unmissable highlight on the healthcare marketing calendar and 2024 will mark the 15th anniversary of the awards.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh